{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-112685","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2024-12-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.683501+00:00","generated_at":"2026-05-28T23:12:21.224162+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"China Pharma rescinds Dec 12 securities purchase agreement; deal void ab initio","bullets":["On Dec 23, 2024, company and an unnamed investor agreed to rescind the Dec 12 securities purchase agreement.","The rescission renders the agreement void from the beginning, as disclosed in prior 8-K filed Dec 13, 2024.","No details on investor or financial impact provided; agreement termination may affect expected capital infusion."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-112685","json":"https://secwatch.observer/filing/0001213900-24-112685.json","markdown":"https://secwatch.observer/filing/0001213900-24-112685.md","text":"https://secwatch.observer/filing/0001213900-24-112685.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390024112685/0001213900-24-112685-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390024112685/ea0226033-8k_china.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:12:21.224162+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}